|
| Status |
Public on Feb 13, 2019 |
| Title |
Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Feb 08, 2019 |
| Last update date |
Mar 21, 2019 |
| Contact name |
Ranmaru Shimoda |
| E-mail(s) |
shimoda@rhelixa.com
|
| Phone |
+818043368250
|
| Organization name |
Rhelixa, Inc.
|
| Street address |
3F Yayoi Bldg., 3-7-4 Iwamotocho
|
| City |
Chiyoda |
| State/province |
Tokyo |
| ZIP/Postal code |
101-0032 |
| Country |
Japan |
| |
|
| Platforms (2) |
| GPL16417 |
Illumina MiSeq (Mus musculus) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
| Samples (32)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE126277 |
IFN-α-producing proliferating myeloid cells reveal type I IFN-stimulating gene signature |
| GSE126278 |
Characterization of tumor-infiltrating T cells by TCR-β repertoire analyses |
| GSE126279 |
Local administration of IFN-α-iPSC-pMCs alters gene expression profiles in tumor microenvironment. |
| GSE126280 |
Allele imbalance in Reps1 and Adpgk |
|
| Relations |
| BioProject |
PRJNA521782 |
Less...
More...